Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- Outcomes of Neuraxial Anesthetic Technique on the Trial of Labor After Cesarean (TOLAC): Complete Statistical AnalysisIndependent statistical analysis of Outcomes of Neuraxial Anesthetic Technique on the Trial of Labor After Cesarean (TOLAC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- OutgrowersIndependent statistical analysis of Stimulating Private Sector Malaria Control: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01397851).
- Outlook Quality of Life Intervention Study: Complete Statistical AnalysisIndependent statistical analysis of Outlook Quality of Life Intervention Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01044290).
- Outlook Quality of Life Intervention: Complete Statistical AnalysisIndependent statistical analysis of Outlook Quality of Life Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00784095).
- OUtMATCHIndependent statistical analysis of Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen OIT in Food Allergic Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Outpatient and Home Advanced Rehabilitation Therapeutics Using Jintronix Virtual Reality Telerehabilitation System: Complete Statistical AnalysisIndependent statistical analysis of Outpatient and Home Advanced Rehabilitation Therapeutics Using Jintronix Virtual Reality Telerehabilitation System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Outpatient Antibiotics Following Previable Rupture of Membranes (pPPROM) Between 18 0/7 and 22 6/7 Weeks Gestational Age: Complete Statistical AnalysisIndependent statistical analysis of Outpatient Antibiotics Following Previable Rupture of Membranes (pPPROM) Between 18 0/7 and 22 6/7 Weeks Gestational Age: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Outpatient Automated Blood Glucose Control With a Bi-hormonal Bionic Endocrine Pancreas: Complete Statistical AnalysisIndependent statistical analysis of Outpatient Automated Blood Glucose Control With a Bi-hormonal Bionic Endocrine Pancreas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Outpatient Chest Tube Management Following Thoracic Resection Improves Patient Length of Stay and Satisfaction Without Compromising Outcomes: Complete Statistical AnalysisIndependent statistical analysis of Outpatient Chest Tube Management Following Thoracic Resection Improves Patient Length of Stay and Satisfaction Without Compromising Outcomes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Outpatient Control-to-Range: System and Monitoring Testing: Complete Statistical AnalysisIndependent statistical analysis of Outpatient Control-to-Range: System and Monitoring Testing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01578980).
- Outpatient Foley Catheter Compared to Usual Inpatient Care for Labor Induction: Complete Statistical AnalysisIndependent statistical analysis of Outpatient Foley Catheter Compared to Usual Inpatient Care for Labor Induction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- OVATIONIndependent statistical analysis of Optimal VAsopressor titraTION Pilot Randomized Controlled Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01800877).
- OVERIndependent statistical analysis of Standard Open Surgery Versus Endovascular Repair of Abdominal Aortic Aneurysm (AAA): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Over Active Bladder Patients Having Sling Surgery: Complete Statistical AnalysisIndependent statistical analysis of Over Active Bladder Patients Having Sling Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00852696).
- Overall Performance of a 1-day Silicone Hydrogel Lens When Habitual Soft Lens Wearers Are Refit: Complete Statistical AnalysisIndependent statistical analysis of Overall Performance of a 1-day Silicone Hydrogel Lens When Habitual Soft Lens Wearers Are Refit: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Overcoming Barriers to the Uptake of Cascade Screening for Lynch Syndrome: Workbook Feasibility Study: Complete Statistical AnalysisIndependent statistical analysis of Overcoming Barriers to the Uptake of Cascade Screening for Lynch Syndrome: Workbook Feasibility Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Overnight Pant Study for Children With Nocturnal Enuresis: Complete Statistical AnalysisIndependent statistical analysis of Overnight Pant Study for Children With Nocturnal Enuresis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05178641).
- Ovicidal Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation: Complete Statistical AnalysisIndependent statistical analysis of Ovicidal Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Ovulation Induction in Women With Clomiphene Citrate Resistant PCOS: Complete Statistical AnalysisIndependent statistical analysis of Ovulation Induction in Women With Clomiphene Citrate Resistant PCOS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01909141).
- OWL-PCOSIndependent statistical analysis of Treatment of Hyperandrogenism Versus Insulin Resistance in Infertile Polycystic Ovary Syndrome (PCOS) Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Ox Bile- Conjugated Bile Acids Sodium in Type II Diabetes Mellitus: Complete Statistical AnalysisIndependent statistical analysis of Ox Bile- Conjugated Bile Acids Sodium in Type II Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- OXA004Independent statistical analysis of Safety and Tolerability Study of Acoziborole in g-HAT Seropositive Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05256017).
- Oxaliplatin and Docetaxel as First-line Therapy for Advanced Non-small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Oxaliplatin and Docetaxel as First-line Therapy for Advanced Non-small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Oxaliplatin and Pemetrexed Disodium in Treating Patients With Refractory Hormone-Resistant Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Oxaliplatin and Pemetrexed Disodium in Treating Patients With Refractory Hormone-Resistant Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Oxaliplatin Microdosing Assay in Predicting Exposure and Sensitivity to Oxaliplatin-Based Chemotherapy: Complete Statistical AnalysisIndependent statistical analysis of Oxaliplatin Microdosing Assay in Predicting Exposure and Sensitivity to Oxaliplatin-Based Chemotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Oxaliplatin-Based Chemotherapy and Chemoradiotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Oxaliplatin-Based Chemotherapy and Chemoradiotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Oxaliplatin, Fludarabine, Cytarabine and Rituximab in Richter’s Syndrome, Refractory CLL and PLL: Complete Statistical AnalysisIndependent statistical analysis of Oxaliplatin, Fludarabine, Cytarabine and Rituximab in Richter's Syndrome, Refractory CLL and PLL: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Oxaliplatin, Fludarabine, Cytarabine, and Rituximab in Patients With Richter’s Transformation and Leukemias: Complete Statistical AnalysisIndependent statistical analysis of Oxaliplatin, Fludarabine, Cytarabine, and Rituximab in Patients With Richter's Transformation and Leukemias: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Oxaliplatin, Gemcitabine and Bevacizumab in Women With Recurrent Mullerian Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Oxaliplatin, Gemcitabine and Bevacizumab in Women With Recurrent Mullerian Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00418093).
- Oxcarbazepine Versus Placebo in Childhood Autism: Complete Statistical AnalysisIndependent statistical analysis of Oxcarbazepine Versus Placebo in Childhood Autism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00467753).
- Oxidative Phosphorylation Inhibitor IACS-010759 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Oxidative Phosphorylation Inhibitor IACS-010759 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Oxidative Stress in Asthma: Complete Statistical AnalysisIndependent statistical analysis of Oxidative Stress in Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04512547).
- OXN PR Tablet 5/2.5 mg and20/10 mg PK Study in Chinese Moderate to Severe Chronic Non-malignant Patients: Complete Statistical AnalysisIndependent statistical analysis of OXN PR Tablet 5/2.5 mg and20/10 mg PK Study in Chinese Moderate to Severe Chronic Non-malignant Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- OXOPT-PCIIndependent statistical analysis of The Oxford Optimisation of PCI Study (OXOPT-PCI Study): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03111940).
- OXT-PWSIndependent statistical analysis of Oxytocin vs. Placebo for the Treatment Hyperphagia in Children and Adolescents With Prader-Willi Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- OXY-RIndependent statistical analysis of Intranasal Oxytocin for the Treatment of Children and Adolescents With Autism Spectrum Disorders (ASD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Oxygen Monitoring of Patients After Surgery on the Hospital General Care Floor: Complete Statistical AnalysisIndependent statistical analysis of Oxygen Monitoring of Patients After Surgery on the Hospital General Care Floor: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Oxygen Reserve Index: Utility as Early Warning for Desaturation in Morbidly Obese Patients: Complete Statistical AnalysisIndependent statistical analysis of Oxygen Reserve Index: Utility as Early Warning for Desaturation in Morbidly Obese Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Oxygen Therapy Use in Patients With Fibrotic Interstitial Lung Disease: Complete Statistical AnalysisIndependent statistical analysis of Oxygen Therapy Use in Patients With Fibrotic Interstitial Lung Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05957198).
- Oxytocin Administration in BDD and OCD: Complete Statistical AnalysisIndependent statistical analysis of Oxytocin Administration in BDD and OCD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02671266).
- Oxytocin and Affect Processing in Posttraumatic Stress Disorder: Complete Statistical AnalysisIndependent statistical analysis of Oxytocin and Affect Processing in Posttraumatic Stress Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02546570).
- Oxytocin and CBSST for People With Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Oxytocin and CBSST for People With Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01752712).
- Oxytocin Effects on Cardiac Electrophysiology: Complete Statistical AnalysisIndependent statistical analysis of Oxytocin Effects on Cardiac Electrophysiology: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01780337).
- Oxytocin Pathways and the Health Effects of Human-Animal Interaction: Complete Statistical AnalysisIndependent statistical analysis of Oxytocin Pathways and the Health Effects of Human-Animal Interaction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03852264).
- Oxytocin Suppresses Substance Use Disorders Associated With Chronic Stress: Complete Statistical AnalysisIndependent statistical analysis of Oxytocin Suppresses Substance Use Disorders Associated With Chronic Stress: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02058251).
- Oxytocin, Alcohol Craving, and Intimate Partner Aggression: Complete Statistical AnalysisIndependent statistical analysis of Oxytocin, Alcohol Craving, and Intimate Partner Aggression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03046836).
- OZGAMIndependent statistical analysis of Effectiveness of OZ439 as a Gametocytocidal and Transmission Blocking Agent: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02431650).
- P03277 Dose Finding Study in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI): Complete Statistical AnalysisIndependent statistical analysis of P03277 Dose Finding Study in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- P1A3BIndependent statistical analysis of Characterization of Brachial Arterial t-PA Release, Endothelial Function, Obesity and Inflammation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- P2Independent statistical analysis of PROSPECT II & PROSPECT ABSORB - an Integrated Natural History Study and Randomized Trial.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…